Search

everythinglearnresearchcommunity

for

Search:↓

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Mitotane changes steroid breakdown, affecting cortisol availability.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Medication 1 improved hair quality and growth more effectively than medication 2 and the placebo.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Chestnut flower extract may help reduce prostate cancer growth.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Liposomes with butterfly pea extract and clove oil are stable and effective according to users.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Anti-cancer drugs are diverse and hard to classify due to their different forms and actions.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Christia vespertilionis extract may help fight breast cancer cells.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Cimetidine does not significantly reduce hair growth in hirsutism.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

Skin and nail changes are common in patients with blood cancers undergoing chemotherapy, affecting their quality of life.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.